Updates on Current States of Cord Blood Expansion Technologies

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Wednesday, October 21, 2020 - On-Demand Available

Master Program Number: 20EL-551 (see program format numbers below under Registration)

Educational Track: Scientific
Topic: Cellular Therapies
Intended Audience: Directors, Hospitals, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientists, Residents/Fellows, Scientists, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Intermediate

Director/Moderator: Mike Halpenny, MLT (CMLTO), Manager, Cord Blood Bank and Stem Cell Manufacturing, Canadian Blood Services, Ottawa, Ontario, Canada
Speakers: Sandra Cohen, MD, Director, In & Out Patient Clinic, Stem Cell Transplant Program, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada; Mitchell E. Horwitz, MD, Director, Adult Blood and Marrow Transplant Program, Duke University Medical Center, Durham, NC

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Define cord blood expansion and its current role in cord blood transplant.
  • Identify current technologies associated with cord blood expansion and equipment used during expansion.
  • Discuss current progress for clinical trials related to cord blood expansion.

Program Description

Cord Blood transplantation continues to face challenges due to low progenitor cell dosage and longer engraftment times. This program will provide an overview and update on cord blood cell expansion technologies. In addition, clinical trial progress will be reported.


   Program #
Single Viewer: On-Demand Register20EL-551-4070
Group Viewing: On-Demand Register20EL-551-8070

Continuing Education Credit

AABB designates both the live and on-demand version of this eCast each to be eligible for 1 continuing education credits/contact hours for California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The number and type of credits awarded for this program (live or on-demand) was determined by the program duration. Please note this program is not eligible for continuing medical education (CME) credit for physicians. For more information on each credit type please visit our Continuing Education Credits webpage.

Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.

Speaker Biographies

Dr. Cohen is the Director of the In and Out Patient Clinic, Stem Cell Transplant Program at Maisonneuve-Rosemont Hospital in Montreal, Canada.

Dr. Horwitz has been at Duke since 2003. He is a professor of medicine and director of adult blood and marrow transplant program, within the Division of Hematologic Malignancy and Cell Therapy. He is an active clinical investigator with research that focuses on adult umbilical cord blood transplantation and post transplant immune recovery. He is a member of the steering committee for the Bone Marrow Transplantation Clinical Trials Network, an NIH-sponsored consortium of stem cell transplant experts who design and conduct cutting edge clinical research.